KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to -$1.6 million.

  • Pacific Biosciences Of California's Change in Receivables rose 4619.67% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 21178.6%. This contributed to the annual value of -$9.1 million for FY2024, which is 15099.0% down from last year.
  • Per Pacific Biosciences Of California's latest filing, its Change in Receivables stood at -$1.6 million for Q3 2025, which was up 4619.67% from $612000.0 recorded in Q2 2025.
  • Pacific Biosciences Of California's 5-year Change in Receivables high stood at $10.8 million for Q1 2023, and its period low was -$6.3 million during Q1 2024.
  • In the last 5 years, Pacific Biosciences Of California's Change in Receivables had a median value of $295000.0 in 2021 and averaged $712684.2.
  • As far as peak fluctuations go, Pacific Biosciences Of California's Change in Receivables skyrocketed by 72000.0% in 2021, and later tumbled by 144576.27% in 2022.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Change in Receivables stood at $295000.0 in 2021, then crashed by 1445.76% to -$4.0 million in 2022, then skyrocketed by 254.38% to $6.1 million in 2023, then crashed by 130.33% to -$1.9 million in 2024, then increased by 11.73% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q3 2025, $612000.0 for Q2 2025, and $4.1 million during Q1 2025.